Advances in Susceptibility Genetics of Intervertebral Degenerative Disc Disease by Zhang, Yin'gang et al.
Int. J. Biol. Sci. 2008, 4 
 
283
International Journal of Biological Sciences 
ISSN 1449-2288 www.biolsci.org 2008 4(5): 283-290 
© Ivyspring International Publisher. All rights reserved 
Review 
Advances in Susceptibility Genetics of Intervertebral Degenerative Disc 
Disease 
Yin’gang Zhang1
, Zhengming Sun1, Jiangtao Liu1, Xiong Guo2 
1.  Department of Orthopaedics of the First Affiliated Hospital, Medical College of Xi’an Jiaotong University, Xi’an, 710061, 
China 
2.  Key Laboratory of Environment and Genes Related Diseases of Ministry of Education, Xi’an Jiaotong University, Xi’an, 
710061, China  

 Correspondence to: Dr. Yin’gang Zhang, Department of Orthopaedics of the First Affiliated Hospital, Medical College of Jiaotong 
University, Xi’an, 710061, China, E-mail: zyingang@mail.xjtu.edu.cn, Tel: +86-029-85323935 
Received: 2008.06.27; Accepted: 2008.08.31; Published: 2008.09.02 
The traditional view that the etiology of lumbar disc herniation is primarily due to age, gender, occupation, 
smoking and exposure to vehicular vibration dominated much of the last century. Recent research indicates that 
heredity may be largely responsible for the degeneration as well as herniation of intervertebral discs. Since 1998, 
genetic influences have been confirmed by the identification of several genes forms associated with disc degen-
eration. These researches are paving the way for a better understanding of the biologic mechanisms. Now, many 
researchers unanimously agree that lumbar disc herniation appears to be similar to other complex diseases, 
whose etiology has both environmental and hereditary influence, each with a part of contribution and relative 
risk. Then addressing the etiological of lumbar disc herniation, it is important to integrate heredity with the en-
vironment factors. For the purpose of this review, we have limited our discussion to several susceptibility genes 
associated with disc degeneration. 
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1. Introduction 
Intervertebral vertebral disc is a link between the 
adjacent two vertebrae, which includes anulus fibro-
sus outside and nucleus pulposus inside. It can buffer 
the pressure came from the upper body and lower 
extremities to maintain the physical height and move-
ment of spine. Lumbar disc herniation is that nucleus 
pulposus protrudes from the defective anulus fibrosus 
because of its degeneration and it’s a common and 
important cause of low back pain. The traditional 
view that the etiology of lumbar disc herniation was 
primarily due to age, gender, occupation, smoking 
and exposure to vehicular vibration dominated much 
of the last century [1]. The contribution of other factors 
such as height, weight and genetics is less certain [2]. 
In recent years, however, a dramatic advance has been 
made in our understanding of genetic influences on 
the risk for disc degeneration, thus changing our tra-
ditional views. Genetic factors, in particular, may be 
largely responsible for the degeneration as well as 
herniation of intervertebral disc [3]. As Ala-Kokko 
concluded in her paper, “Even though several envi-
ronmental and constitutional risk factors have been 
implicated in this disease, their effects are relatively 
minor. And recent family and twin studies have sug-
gested that sciatica, disc herniation and disc degenera-
tion may be explained to a large degree by genetic 
factors” [4]. Now, many researchers unanimously 
agree that lumbar disc herniation appears to be similar 
to other complex diseases, whose etiology has both 
environmental and hereditary influence, each with a 
part of contribution and relative risk. Then addressing 
the etiological of lumbar disc herniation, it is impor-
tant to integrate heredity with the environment fac-
tors. For the purpose of this review, we have limited 
our discussion to several susceptibility genes associ-
ated with disc degeneration. Following is a brief re-
view regarding the genetics of disc degeneration, se-
lected from more extensive articles on the same sub-
ject. 
2. Familial Aggregation of Disc Degeneration 
and Heritability 
The first step in the study of genetic epidemiol-
ogy is typically to determine if there is a familial ag-Int. J. Biol. Sci. 2008, 4 
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gregation of the condition or the disease of interest, 
which suggests the possibility of a genetic influence. 
In 1991, Varlotta et al [5] found that 32% of ado-
lescent patients with disc herniation had a family his-
tory. Matsui et al [6] reported that there is familial 
c l u s t e r i n g  o f  l u m b a r  d i s c  herniation among the en-
cumbrances of 18-year-old or younger patients with 
lumbar disc herniation. Subsequently, in 1995, Battie 
et al [7] assessed lumbar MRIs of 115 pairs of male 
monozygotic twins, to investigate the relative effects 
of environmental risk factors, age and familial aggre-
gation on disc degeneration. Disc bulging, height nar-
rowing, and disc desiccation as indicated through 
signal intensity were used as phenotypic clinical 
markers. In a multivariable analysis of the No.12 tho-
racic–No.4 lumbar vertebrae region, physical loading 
exposures explained 7% of the variance in disc degen-
eration scores among the 230 subjects, with the addi-
tion of age to 16% and with the addition of a variable 
representing familial aggre g a t i o n  t o  7 7 % .  I n  t h e  
No.4–5 lumbar vertebrae and No. 5 lumbar-No.1 sac-
ral vertebrae region, physical loading measures ex-
plained only 2% of the variance in disc degeneration 
summary scores in multivariable analysis. The vari-
ance score in lower lumbar rose to 9% with the addi-
tion of age and to 43% with the addition of familial 
aggregation. This study provided the first estimate of 
the relative importance of specific environmental 
agents and overall familial influences including ge-
n e t i c  f a c t o r s .  I n  1 9 9 7 ,  M a t s u i  e t  a l  [ 8 ]  a n a l y z e d  r e -
sponses from a questionnaire given by 3, 042 Japanese 
workers at a factory. They found that the average age 
of the first attack of low back pain in workers whose 
parents also suffered from the same condition, was 
significantly younger than that in workers with no 
similar history. 
After the evidence for familial aggregation of 
disc degeneration was established, there was a need to 
distinguish between biologic (genetic) and social (cul-
tural inheritance) sources of familial similarity. Sam-
brook et al [9] conducted a classic twin study to ex-
amine the hypothesis that disc degeneration has a 
major genetic component. Spine MRIs were obtained 
from 86 pairs of monozygotic twins and 154 dizygotic 
twins, 80% of whom were female, from Australian and 
British twin registries. A substantial genetic influence 
on disc degeneration was found. For a summary score 
of disc degeneration, comprised of disc height, signal 
intensity, bulging, and anterior osteophyte formation, 
heritability estimates were very high, 74% (95% confi-
dence interval, 64%–81%) for the lumbar spine and 
73% (95% confidence interval, 64%–80%) for the cer-
vical spine, after adjusting for age, weight, smoking, 
occupation, and physical activity. The analysis on the 
individual MRI findings suggested that disc bulging 
and height were the primary contributors to genetic 
determination of the disc degeneration summary 
score. However, the genetic influence on signal inten-
sity was not apparent. 
In summary, the observations and studies in ju-
veniles and adults of familial aggregation make a con-
vincing case that intervertebral disc herniation is in-
deed influenced by familial factors. The studies do 
not, however, provide data on the relative contribu-
tions of genetic and shared environmental factors 
among family members. However, these findings in-
dicate that stronger genetic effects are associated with 
an earlier onset of intervertebral disc degeneration. 
 
3. Approaches in studying genetic traits of 
lumbar disc herniation 
At present, approaches of genome-wide scan and 
candidate-gene have been used in the study of com-
plex diseases by single nucleotide polymorphism 
(SNPs), which is used as a genetic marker. The candi-
date-gene approach has been widely used to study 
susceptibility genes of complex diseases [10]. By lit-
erature searches, researchers would find disc metabo-
lism pathway specific-genes, which may be correlated 
with phenotype of lumbar disc herniation. Then, pa-
tients with final diagnosis and normal controls 
matched with the study group are researched by a 
case–control study and association study, to compare 
SNPs of candidate-gene that play a key role in the 
pathway of disc metabolism or locate the relative do-
main of chromosome. Its purpose is to select potential 
susceptible gene by analyzing whether the frequency 
of gene in two groups has statistical difference. There 
are four major categories of candidate-genes related to 
lumbar disc disease (Fig. 1). Category 1 includes the 
genes association with the construction of the struc-
tural component of the intervertebral disc, such as the 
aggrecan gene and the collagen IX gene. Category 2 
consists of genes that produce the degradation en-
zymes of the disc matrix, for example, the matrix met-
alloprotease-3 gene. Category 3 is comprised of the 
genes related to bone structure. The osteoporosis re-
lated genes, vitamin-D receptor and  estrogen receptor 
genes, are implicated in lumbar disc disease. Category 
4 is others. 
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Figure 1. Categories of candidate-genes related to lumbar disc disease. Note COL=Collage; CILP=cartilage intermediate layer 
protein; MMP=Matrix metalloprotease; IL=interleukin; VDR=Vitamin D receptor; ER=estrogen receptor; Sox9=SRY 
(sex-determining region Y)-box9 encoding 
 
4. Candidate-gene polymorphisms associated 
with disc degeneration 
4.1 Type IX collagen 
Collagen IX, a structural component of nucleus 
pulposus and annulus fibrosus of intervertebral disc, 
is considered to serve as a bridge between collagens 
and non-collagenous proteins in tissues. It is a hetero-
trimer of three Alpha chains, 1(IX), 2(IX), and 3(IX), 
encoded by the genes COL9A1, COL9A2, and COL9A3, 
respectively. It consists of three collagenous (COL1 to 
COL3) and four non-collagenous (NC1 to NC4) do-
mains [11]. Collagen IX shares an important role to 
constitute intervertebral disc, so gene encoding colla-
gen IX is suitable candidate-genes. And COL9A2 and 
COL9A3 genes are relatively better studied than 
COL9A1 (references see below). Transgenic mice ex-
pressing mutant alpha 1(IX) collagen were reported to 
have accelerated disc degeneration [12]. 
4.1.1 COL9A2 
In 1999, Annunen et al [13] pointed out that allele 
of COL9A2 act a significant role in the pathogenesis of 
disc disease. Studies indicated a heterozygous substi-
tution of Trp for either Gln326 or Arg326 in the COL2 
domain changed the structure of collagenous domains 
of COL2. Because Trp is rarely found in collagenous 
domains, there are no Trp residues in the collagenous 
domains of collagen IX in humans or in the mouse 
[14]. Like many hydrophobic amino acids, Trp may 
disrupt the collagen triple helix, as well as interfere 
with the interaction between collagens IX and II or 
prevent the action of lysyl oxidase, which catalyzes 
cross-link formation, and thus cause disc disease. 
Annunen et al used conformation sensitive gel elec-
trophoresis to analyze all the exons and exon bounda-
ries of COL9A2 in patients with the Trp substitution. 
The analysis did not identify any other possible causes 
of the disease in the coding sequences or RNA splice 
sites, but it indicated two additional changes, an A to 
G change affecting the third nucleotide in the codon 
for proline (CCA to CCG) at nucleotide 9 in exon 21, 
and a G to A change at nucleotide +17 in intron 30. 
An outcome of conspicuous heredity and phe-
notype was discovered in a Finnish population carry-
ing allele COL9A2 with the Trp (Trp2) substitution. 
The Trp2 allele was found in 6 of 157 Finnish patients 
(4%) but in none of 174 control individuals. Coinheri-
tance of the Trp2 allele and the phenotype was studied 
in the families of four original patients. All members 
who had inherited the allele in these families had in-
tervertebral disc disease [13]. Jim et al [15] reported 
that Trp2 allele has a higher frequency in a Southern 
Chinese population than in a Finnish population. The 
Trp2 allele was present in 20% of 804 samples. Af-
fected Trp2 individuals had more severe degeneration, 
moreover, the association was age-dependent [15, 16]. 
Seki et al [17] reported Trp2 was common in Japanese, 
and no association with lumbar disc degeneration was 
apparent. However, association of a COL9A2 specific 
haplotype with lumbar disc degeneration was de-
tected. Accordingly, the allelic variation of COL9A2 Int. J. Biol. Sci. 2008, 4 
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that is associated with lumbar disc disease is depend-
ent on race and nationality.   
4.1.2 COL9A3 
In the case-control study of the Finnish popula-
tion of relative homogeneity, Petteri et al [18] found 
that for an individual carrying allele COL9A3 with the 
Trp (Trp3) substitution, the risk of disc disease in-
creased nearly 3-fold compared with an individual 
without Trp3. The site of mutation was an 
Arg103→Trp substitution in the a3 (IX) chain 
(Trp3allele). A study of 164 individuals with lumbar 
disc disease and 321 controls (186 healthy, 83 with os-
teoarthritis, 31 with rheumatoid arthritis, and 21 with 
chondrodysplasia), showed the frequency of the Trp3 
allele as 12.2% in the case sample and 4.7% in the con-
trol group, the differences were statistically signifi-
cant. The results indicated that the Trp3 allele may 
cause lumbar disc disease. But, it is noteworthy that 
the association with Trp3 allele in the Finnish popula-
tion has not been successfully replicated in the Greek 
population [19]. 
Solovieva’s [20] study found that the carriage of 
the Trp3 allele in the absence of the IL-1betaT (3954) 
allele increased the risk of dark nucleus pulposus and 
joint occurrence of degenerative changes by MRI. 
There was no effect of the Trp3 allele on disc degen-
eration in the presence of the IL-1betaT (3954) allele. 
The outcomes suggest that the effect of the COL9A3 
gene polymorphism on disc degeneration may be 
modified by the IL-1beta gene polymorphism. The 
Trp3 allele was also associated with radiographic fea-
tures of Scheuermann disease [21]. 
Solovieva et al [22] had further researched the 
relation of gene-environment interaction, and found 
t h at  in c i den c e rat e  o f  l u m b ar d isc  de gen erat io n  w as 
increased for interactions of the mutation of COL9A3 
gene with persistent load on disc. In a study of 135 
male individuals with Trp3, it was discovered that the 
incidence rate of lumbar disc degeneration was 71% in 
obese patients compared with only 45% in subjects 
who were not obese. It is thus evident that prevalence 
of disc degeneration could be strikingly increased 
when there is the synergistic effect of 
gene-environment interaction. 
4.2 Type I collagen 
Collagen I is an important ingredient of bone and 
anulus fibrosus of disc. Pluijm et al [23] and Tilkeridis 
et al [24] reported that the risk of disc degeneration for 
people with the TT genotype was higher than people 
with the GG or GT genotype. Mann found that pres-
ence of the T allele in the COLIA1 Sp1 binding site has 
functional effects on the collagen gene regulation that 
leads to a higher COLIA1 mRNA expression level, an 
increase COLIA1 protein expression level and 
COLIA1/COLIA2 protein ratios [25]. An abnormal 
ratio of collagen is associated with impaired bone 
structure. Moreover, the intronic polymorphism of the 
Sp1 binding site of COLIA1 may affect the transcrip-
tion of collagen I. There may be interactions with other 
genes or environmental factors. However, how defects 
in collagen I influence the development of disc degen-
eration is still unclear and needs further investigation. 
The relative interpretation between gene and disease 
has disparity. Therefore, association analysis with 
large sample size is indispensable to research the rela-
tion between the Sp1 binding site of COLIA1 and disc 
degeneration. 
4.3 Type IV and X collagen 
Wang et al [26] reported that type IV collagen 
occurring in the disc of adolescents is the result of 
early cellular reaction to harmful stimuli, and this can 
serve as a biological marker for early degeneration of 
human lumbar intervertebral discs. Nerlich et al [27] 
found that collagen type X was expressed by nuclear 
chondrocytes at a higher age and was associated with 
advanced degenerative disc alterations. Hence both of 
them may be taken as molecular markers of disc de-
generation. To date, there are no known associations 
of polymorphisms in collagen type IV and/or collagen 
type X genes, with intervertebral disc disease. 
4.4 Sox9 
Sox9 is one of a family of genes related to the 
mammalian Y-linked, testis-determining gene Sry [28]. 
Sox genes appear to encode transcription factors with 
diverse roles in differentiation and development. Sox9 
is expressed in mesenchymal condensations prior to 
and during chondrogenesis, and it has been shown to 
activate Col2a1, the gene encoding type II collagen, 
the major component of cartilage matrix [29, 30]. Sox9 
has been shown to regulate the genes encoding ag-
grecan [31] and type XI collagen [32], and may also 
regulate other structural and/or patterning gene in-
volved in cartilage and bone development [33]. Ex-
pression and regulation of Sox9 gene also were seen at 
the nucleus pulposus cells [34].   
Paul et al [35] have explored the use of Sox9 gene 
therapy for degenerative disc disease. They used ade-
noviral delivery vectors expressing Sox9 to infect a 
chondroblastic cell line and human disc cells; Sox9 and 
Type II collagen production increased. In addition, 
AdSox9 virus was injected directly into the discs of 
rabbits, they have reported that the expression was 
preserved for 5 weeks. Gruber et al considered that 
loss of expression of Sox9 in some of the anulus cell 
population may play a role in disc aging and degen-
eration, possibly by decreased modulation of the ex-Int. J. Biol. Sci. 2008, 4 
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pression and production of Type II collagen of disc 
cells [36]. Sox9 is co-expressed with Col2a1. Mutation 
and polymorphism of Sox9 gene and association with 
intervertebral disc degeneration remain to be studied. 
4.5 Vitamin D receptor  
Studies found that Vitamin D receptor play an 
important role in normal bone mineralization and re-
modeling, and its gene polymorphisms are thought to 
correlate with some disease. Videman et al [37] and 
Kawaguchi et al [38] reported that subjects with the tt 
or Tt allele of the vitamin-D receptor gene were more 
frequently associated with multilevel and severe disc 
degeneration and disc herniation than ones with the 
TT allele. They pointed an increased risk of disc dis-
ease at an early age in subjects with the Tt allele in the 
vitamin-D receptor gene. On the other hand, in an 
evaluation of the association between allelic variations 
in the vitamin-D receptor gene and spinal degenerative 
disease, Jones et al [39] found a sharp decrease in the 
risk of spinal osteophytosis and the presence of disc 
narrowing between tt and  TT. Spinal osteophytosis 
and disc narrowing are closely related to disc degen-
eration. Furthermore, Videman et al [40] found two 
intragenic polymorphisms of the vitamin  D  receptor 
gene associated with disc degeneration. Quantitatively 
assessed signal intensities of thoracic and lumbar 
(No.6 thoracic–No.1 sacral vertebrae) discs were 12.9% 
worse in men with the Taql tt genotype and 4.5% 
worse in men with the Tt genotype, compared with 
signal intensity in men with the TT genotype. A simi-
lar pattern was found between disc signal intensity 
and  Fok l polymorphisms; men with the ff and Ff 
genotypes had mean signal intensities that were 9.3% 
and 4.3% lower, respectively, than those in men with 
FF genotypes. The summary scores of qualitatively 
assessed signal intensity, bulging, and disc height 
were 4.0% and 6.9% worse in men with Ff  and  ff 
genotypes, respectively, when compared with those in 
men with the FF genotype. Cheung et al [41] had fur-
ther confirmed that the t allele of vitamin D receptor Taq 
I was associated with a high risk of degenerative disc 
disease and disc bulge developing, especially in indi-
viduals younger than 40 years. 
It has been reported that the vitamin-D receptor 
is expressed not only in osteoblasts [42] but also in the 
chondrocytes [43]. Balmain et al found immunoreac-
tive vitamin-D receptor in the nucleoli of the chon-
drocyte, particularly in the fibrillar component, sug-
gesting that vitamin D is directly involved in the dif-
ferentiation, proliferation, and maturation of cartilage 
cells. In addition, vitamin D can influence proteogly-
can synthesis by articular chondrocytes in vitro [44]. 
Since the intervertebral disc is also rich in proteogly-
can, these findings suggest that the vitamin-D receptor 
may be directly involved in the pathophysiology of 
the degenerated intervertebral disc. At present, it is 
still unknown how the genetic variants of the vitamin- 
D receptor gene affect the clinical presentation of disc 
disease. Kawaguchi et al speculated that this poly-
morphism in the vitamin-D receptor gene might alter 
the structural characteristics of the matrix in the in-
tervertebral disc [38]. Furthermore, he further consid-
ered the possibility that vitamin-D receptor gene 
polymorphism is not directly involved in the patho-
genesis of lumbar disc disease but merely a marker for 
other genes. The vitamin-D receptor gene is located on 
chromosome 12q12 [45]. The type-2 collagen (COL2A1) 
gene and insulin-like growth factor (IGF) type-1 gene are 
also located nearby [46]. It is likely genetic marker of 
degenerative disc disease. 
4.6 Matrix metalloprotease-3  
Studies suggest that matrix metalloprotease-3 
(MMP-3) has an important role in the degeneration of 
intervertebral discs [47]. MMP-3 expression is induced 
in response to local conditions such as mechanical 
loading [48] and inflammation [49]. A common 5A/6A 
polymorphism in the promoter region of the human 
MMP-3 gene has been identified [50].This polymor-
phism was reported to be involved in the regulation of 
MMP-3 gene expression with the 5A allele having 
twice as much promoter activity as the 6A allele [51]. 
Takahashi et al [52] studied elderly Japanese subjects, 
and found that the 5A5A and 5A6A genotype in the 
elderly was associated with a significantly larger 
number of degenerative intervertebral discs than the 
6A6A, but there was no significant difference in the 
young. These studies indicate that the 5A allele of the 
human MMP-3 promoter may be a crucial risk factor 
for the acceleration of intervertebral disc degeneration, 
especially in the older population. 
4.7 Interleukin-1  
Inflammatory cytokines have a well-recognized 
contribution to the generation of back pain. Inter-
leukin-1 in particular contributes to disc degeneration 
by inducing enzymes that destroy proteoglycan and it 
is involved in the mediation of pain. Solovieva et al 
[53, 54] have demonstrated an association between 
interleukin-1 polymorphisms and features of disc de-
generation on magnetic resonance imaging in male 
Finnish workers. The TT genotype of the IL-1 gene 
was associated with more than a 3-fold increase in the 
risk of disc bulges among middle-aged occupationally 
active men. The polymorphisms were associated with 
a 2.5-fold increased risk of back pain, and an associa-
tion was also seen with the intensity and duration of 
pain together, with the degree of functional limitation. Int. J. Biol. Sci. 2008, 4 
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Ye et al [55] have suggested -511T>C SNP in IL-1β 
gene associates with Lumbar disc disease in Chinese. 
Besides, Valdes have tested polymorphisms of 
genes that express inflammatory factors, and found 
some of the same polymorphisms, such as CD36, 
COX2, NCOR2, TNA and ESR1, affecting knee OA 
susceptibility, were also associated with radiographic 
progression of lumbar disc degeneration [56]. Poly-
morphisms of gene of cartilage intermediate layer 
protein were associated with the pathogenesis of 
lumbar disc disease [57]. 
5. Overview 
Lumbar disc degeneration is not only regulated 
by multiple genes and some environmental factors, 
but also gene-gene interactions and gene-environment 
interactions may also exist. At present, the study of 
allele of COL9A2 is more extensive than the other 
genes associated with lumbar disc disease. However, 
it is necessary for long-term study and research to in-
tegrate larger sample size with clinical and controlled 
study of different populations. Study of allele of 
COL9A3, vitamin D receptor and matrix metalloprotease-3 
gene were only confined to the superficial correlation 
of elementary and clinical research. Hereditary and 
mechanism of these genes are still unknown. The role 
of collagen and its gene mutation, which occur fre-
quently in the pathogenesis of lumbar disc disease, 
has been researched to a certain extent. However, it is 
essential to perform further research in order to better 
understand the interrelation of genetic genes and en-
vironmental factors. With the continual development 
of genome-wide scan, effective means is offered to 
find numerous genes, each with a small overall con-
tribution to the pathogenesis of lumbar disc degenera-
tion. Researchers may delimit a specific domain by 
genome-wide scan and then scan eligible SNPs located 
in the domain, find virulence genes by analysis of 
linkage disequilibrium, in order to search for early 
biomarkers for susceptible individuals. 
Although the complex contributions and interac-
tions of genetic and environmental factors are largely 
unknown, work has begun in this area. On the whole, 
genetic study with relation to lumbar disc disease 
would offer new evidence for prevention and cure of 
lumbar disc disease. 
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